Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early erectile rehabilitation with Sildenafil after radiotherapy and proctectomy for rectal cancer (RECTIL)
2020-002682-34Phase 3Active
- Sponsor
- Rouen University Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of sildenafil in rectal cancer and erectile dysfunction (ED) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Responder rate for erectile function at 12 months post-operatively. Started Jan 2023; status: active.
02
Drugs
sildenafil
03
Conditions
rectal cancererectile dysfunction (ED)
Beyond the preview
Go deeper on 2020-002682-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-002682-34.